❌

Normal view

Cognitive bias in LLM reasoning compromises interpretation of clinical oncology notes

arXiv:2511.20680v1 Announce Type: cross Abstract: Despite high performance on clinical benchmarks, large language models may reach correct conclusions through faulty reasoning, a failure mode with safety implications for oncology decision support that is not captured by accuracy-based evaluation. In this two-cohort retrospective study, we developed a hierarchical taxonomy of reasoning errors from GPT-4 chain-of-thought responses to real oncology notes and tested its clinical relevance. Using breast and pancreatic cancer notes from the CORAL dataset, we annotated 600 reasoning traces to define a three-tier taxonomy mapping computational failures to cognitive bias frameworks. We validated the taxonomy on 822 responses from prostate cancer consult notes spanning localized through metastatic disease, simulating extraction, analysis, and clinical recommendation tasks. Reasoning errors occurred in 23 percent of interpretations and dominated overall errors, with confirmation bias and anchoring bias most common. Reasoning failures were associated with guideline-discordant and potentially harmful recommendations, particularly in advanced disease management. Automated evaluators using state-of-the-art language models detected error presence but could not reliably classify subtypes. These findings show that large language models may provide fluent but clinically unsafe recommendations when reasoning is flawed. The taxonomy provides a generalizable framework for evaluating and improving reasoning fidelity before clinical deployment.

Rigor in AI: Doing Rigorous AI Work Requires a Broader, Responsible AI-Informed Conception of Rigor

arXiv:2506.14652v2 Announce Type: replace-cross Abstract: In AI research and practice, rigor remains largely understood in terms of methodological rigor -- such as whether mathematical, statistical, or computational methods are correctly applied. We argue that this narrow conception of rigor has contributed to the concerns raised by the responsible AI community, including overblown claims about the capabilities of AI systems. Our position is that a broader conception of what rigorous AI research and practice should entail is needed. We believe such a conception -- in addition to a more expansive understanding of (1) methodological rigor -- should include aspects related to (2) what background knowledge informs what to work on (epistemic rigor); (3) how disciplinary, community, or personal norms, standards, or beliefs influence the work (normative rigor); (4) how clearly articulated the theoretical constructs under use are (conceptual rigor); (5) what is reported and how (reporting rigor); and (6) how well-supported the inferences from existing evidence are (interpretative rigor). In doing so, we also provide useful language and a framework for much-needed dialogue about the AI community's work by researchers, policymakers, journalists, and other stakeholders.

Smart spatial omics (S2-omics) optimizes region of interest selection to capture molecular heterogeneity in diverse tissues

Nat Cell Biol. 2025 Nov 26. doi: 10.1038/s41556-025-01811-w. Online ahead of print.

ABSTRACT

Spatial omics technologies have transformed biomedical research by enabling high-resolution molecular profiling while preserving the native tissue architecture. These advances provide unprecedented insights into tissue structure and function. However, the high cost and time-intensive nature of spatial omics experiments necessitate careful experimental design, particularly in selecting regions of interest (ROIs) from large tissue sections. Currently, ROI selection is performed manually, which introduces subjectivity, inconsistency and a lack of reproducibility. Previous studies have shown strong correlations between spatial molecular patterns and histological features, suggesting that readily available and cost-effective histology images can be leveraged to guide spatial omics experiments. Here we present Smart Spatial omics (S2-omics), an end-to-end workflow that automatically selects ROIs from histology images with the goal of maximizing molecular information content in the ROIs. Through comprehensive evaluations across multiple spatial omics platforms and tissue types, we demonstrate that S2-omics enables systematic and reproducible ROI selection and enhances the robustness and impact of downstream biological discovery.

PMID:41298871 | DOI:10.1038/s41556-025-01811-w

Human Experts' Evaluation of Generative AI for Contextualizing STEAM Education in the Global South

arXiv:2511.19482v2 Announce Type: replace-cross Abstract: This study investigates how human experts evaluate the capacity of Generative AI (GenAI) to contextualize STEAM education in the Global South, with a focus on Ghana. Using a convergent mixed-methods design, four STEAM specialists assessed GenAI-generated lesson plans created with a customized Culturally Responsive Lesson Planner (CRLP) and compared them to standardized lesson plans from the Ghana National Council for Curriculum and Assessment (NaCCA). Quantitative ratings were based on a validated 25-item Culturally Responsive Pedagogy Rubric measuring bias awareness, cultural representation, contextual relevance, linguistic responsiveness, and teacher agency. Qualitative reflections provided additional insight into how GenAI handles cultural and pedagogical appropriateness. Findings show that GenAI, when paired with the CRLP tool, can support contextualized STEAM instruction by linking abstract curriculum standards to learners' cultural knowledge, community practices, and everyday experiences. Experts rated GenAI-assisted lessons as more culturally grounded and pedagogically responsive than NaCCA plans, integrating Indigenous knowledge, bilingual elements, and locally relevant examples. However, GenAI struggled to represent Ghana's cultural pluralism, often offering surface-level references to language, history, and identity. These weaknesses were most evident in Mathematics and Computing, where cultural nuance was limited. The results highlight the need for continued teacher mediation, community involvement, and culturally attuned refinement of AI outputs. Future work should include classroom trials, expanded expert participation, and model fine-tuning using Indigenous language corpora to strengthen cultural fidelity in Global South contexts.

Precision Oncology: Current Landscape, Emerging Trends, Challenges, and Future Perspectives

26 November 2025 at 19:00

Cells. 2025 Nov 17;14(22):1804. doi: 10.3390/cells14221804.

ABSTRACT

Precision oncology is broadly defined as cancer prevention, diagnosis, and treatment specifically tailored to the patient based on his/her genetics and molecular profile. In simple terms, the goal of precision medicine is to deliver the right cancer treatment to the right patient, at the right dose, at the right time. Precision oncology is the most studied and widely applied subarea of precision medicine. Now, precision oncology has expanded to include modern technology (big data, single-cell spatial multiomics, molecular imaging, liquid biopsy, CRISPR gene editing, stem cells, organoids), a deeper understanding of cancer biology (driver cancer genes, single nucleotide polymorphism, cancer initiation, intratumor heterogeneity, tumor microenvironment ecosystem, pan-cancer), cancer stratification (subtyping of traditionally defined cancer types and pan-cancer re-classification based on shared properties across traditionally defined cancer types), clinical applications (cancer prevention, early detection, diagnosis, targeted therapy, minimal residual disease monitoring, managing drug resistance), lifestyle changes (physical activity, smoking, alcohol consumption, sunscreen), cost management, public policy, and more. Despite being the most developed area in precision medicine, precision oncology is still in its early stages and faces multiple challenges that need to be overcome for its successful implementation. In this review, we examine the history, development, and future directions of precision oncology by focusing on emerging technology, novel concepts and principles, molecular cancer stratification, and clinical applications.

PMID:41294857 | PMC:PMC12651332 | DOI:10.3390/cells14221804

❌